Featured
10 innovative drugs land on TGA review desk
Australia's medicines regulator has accepted an additional 10 Type A applications between June and July, with some pegged blockbusters making the list
Jobs & Workplace
Senior leadership shake-up sweeps industry
There has a been a rush on senior leadership moves across industry with a string of departures, returns, company moves and internal promotions
Regulatory & Reimbursement
Chilling forecast on future PBS spending
The Federal Government's Intergenerational Report forecasts PBS spending will grow more slowly than health spending as a whole
Industry & Companies
Telix pays $3.3B to lock up the market
The local giant has shored up isotope supply for its late-stage pipeline with the icing on the cake, acquiring a radiopharmaceutical on the cusp of winning FDA approval
Featured
Copycats hit PBS bottleneck
Biosimilar and generic drugmakers have emerged as the top contenders to secure an October PBS listing, including one drug that could force a price cut for a $72 million-a-year blockbuster
Latest
Novo dragged into horror DV weekend
Media reports of a spate of domestic violence homicides over the weekend included one accused's defence that he was affected by Ozempic.
Regulatory & Reimbursement
Novel therapy heading to Australia
Under an expanded deal, this company has snagged Australian rights to a new topical formulation of a well-known JAK inhibitor
Regulatory & Reimbursement
Early October listings climb to four
Health Minister Mark Butler announces another two October listings, one of which will benefit more than 143,000 Australians from the start of next month
Jobs
Regulatory & Reimbursement
TGA approves new flu jab
A new vaccine has been approved by the TGA for adults along with new versions of drugs sponsored by Celltrion Healthcare, Kyowa Kirin, and UCB.
Regulatory & Reimbursement
Policy 'earthquake' reshaping pharma
In what's been described as the biggest industry transformation in 30 years, pharma is facing a 'commercialisation reset' on how it does business
Jobs & Workplace
Ex-pharma leader joins fast-growing agency
A corporate and strategic communications advisory agency has buffed up its team with a former J&J and Novartis corporate affairs leader joining the ranks
Featured
Another Aussie CEO departs for 'personal reasons'
Leaving after 24 years, this latest exit follows a string of CEO departures across Australia’s biotech sector
Regulation & Legal
New law gives patients driving exemption
Medicinal cannabis patients in NSW will no longer have to choose between taking their medicine or driving after reforms abolish automatic license loss and heavy fines
Industry & Companies
Australia a key market for new platform
Transforming Medical Information into a strategic source of intelligence for pharmas by unlocking more value from every scientific interaction
Industry & Companies
Pharma skyrockets up World's Best Companies list
After placing 43rd last year this pharma has blasted up the rankings to be named the world's fifth best company, trouncing industry rivals
Regulatory & Reimbursement
Another October listing as Govt rushes to beat deadline
A harried Government has announced politically urgent PBS funding for a drug to replace one that is being pulled from the Scheme in November
Regulatory & Reimbursement
PBAC to PBS: the fastest-moving submissions
Two months on from the PBAC's July meeting, just over 60 per cent of the submissions recommended have started progressing towards a PBS listing
Leadership & People
Who's given Mark Butler an award?
Politicians are more likely cop flak than awards but the Health Minister has won a prestigious gong for his handling of an issue that's sparked a spat between patient groups
Industry & Companies
Amgen releases roadmap for post-cardiac care
With a third of cardiac events being repeats, Amgen has co-authored a report to address gaps in post-hospital care
Industry & Companies
Significant job cuts hit pharma, with ANZ GM let go
ANZ General Manager among those being let go as “overlapping roles” are made redundant following a recent buyout
Leadership & People
Who's been named a top employer?
Judged on leadership, engagement, communication and employee benefits this Big Pharma has taken home a prestigious Australian HR award
Regulatory & Reimbursement
People are dying, where's the access?
A LifeSciences Australia Summit has been told that HTA reforms which the Govt has been sitting on for more than five years are already out of date
Industry & Companies
Second pharma joins Medicines Australia
Another company has joined Medicines Australia as a Class 1 Member this month, with its ANZ chief revealing why it is a pivotal time for industry to speak up
- Industry & Companies Which Big Pharma is changing its name?
- Regulation & Legal A decade on, judge rules biosimilar not infringing
- Regulation & Legal 'Faster acting' claim lands in Federal Court
- Industry & Companies Fertility a workplace issue: Merck survey
- Industry & Companies $50K research prize up for grabs
- Industry & Companies Sanofi exposes critical ‘GP gap’ in Australia
- Jobs & Workplace Ex-Aussie GM wins global promotion
- Industry & Companies Why Australia can't win against Trump's MFN policy
- Other News Doctors feel the fear but do it anyway
- Industry & Companies 'The Novo Way' marks a new way of working
- Other News Never heard of it: disease gap exposed
